Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

oncolytic vaccinia virus OVV-01

An oncolytic vaccinia virus (VV), with potential immunomodulating and antineoplastic activities. Upon intratumoral administration of the oncolytic vaccinia virus OVV-01, the virus preferentially targets and infects tumor cells, thereby causing oncolysis. In turn, the lysed tumor cells release various tumor-associated antigens (TAAs), which induce an immune response against the tumor cells. This further kills tumor cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	oncolytic virus OVV-01
Code name:	C045 OVV 01 OVV-01 OVV01

oncolytic vaccinia virus OVV-01

Search NCI's Drug Dictionary